University of Khartoum: Clinical Trials

24 trials sponsored by University of Khartoum, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 10 unknown, 1 active not recruiting. 7 Phase 2, 6 Phase 4, 4 Phase 3, 3 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Unknown 4, Completed 3
Phase 46Unknown 4, Completed 2
Phase 34Completed 2, Unknown 2
Not applicable3Unknown 2, Completed 1
Phase 11Unknown 1

Follow University of Khartoum: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Knowledge of Students About Vitamin A and Assessment of Eye Manifestations in Quranic Schools (Khalwai) Khartoum State, Sudan 2022
Vitamin A Deficiency, Night Blindness
CompletedUniversity of Khartoum3322022-11-012025-05-25
Abbott NxTekTM Malaria RDT WHO Prequalification Study
Rapid Diagnostic Test - Malaria, RDT
CompletedFoundation for Innovative New Diagnostics, Switzerland45632022-06-302023-10-13
A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis
Sodium stibogluconate / paramomycin - Visceral Leishmaniasis
Active not recruitingUniversity of York2162022-05-222025-07-24
RapiGEN BIOCREDIT Malaria Ag RDTs WHO Prequalification Study
Rapid diagnostic test - Malaria, Diagnoses Disease
CompletedFoundation for Innovative New Diagnostics, Switzerland6742021-12-012023-10-13
Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients
Acacia Senegal, Pectin - COVID 19
Phase 2 / Phase 3UnknownAl-Neelain University1102020-06-012020-05-12
Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients
Acacia Senegal extract, Pectin - Sickle Cell Anemia in Children
Phase 2 / Phase 3UnknownAl-Neelain University1002020-02-152020-01-28
Effects of Gum Arabic on Metabolic Syndrome Parameters in Postmenopausal Women
Gum Arabic - Metabolic Syndrome in Postmenopausal Females
Phase 2CompletedUniversity of Khartoum1002019-12-042026-02-18
Tissue Microenvironment Signatures of the Mycetoma Granuloma
Mycetoma
CompletedUniversity of Khartoum282019-03-072020-05-26
Effects of Gum Arabic Supplementation in Hemodialysis Patients
Gum Arabic, Placebo - Kidney Failure, Chronic
Not applicableUnknownUniversity of Khartoum802018-11-012019-01-03
Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation
Antithymocyte Immunoglobulin (Rabbit), Interleukin 2 Receptor Antagonist - Kidney Transplant Rejection
Phase 4UnknownUniversity of Khartoum3002018-03-212019-01-03
The Effects of Folic Acid on Sudanese Women With Polycystic Ovary Syndrome
Folic Acid - Polycystic Ovary Syndrome
Phase 1 / Phase 2UnknownUniversity of Khartoum902017-09-012017-08-31
Gum Arabic as Antioxidant and Anti-inflammatory in Hemodialysis Patients
Gum Arabic - End-Stage Renal Disease
Not applicableUnknownLamis Kaddam502017-07-012017-07-11
Risk of Malignancy in Endemic Long Standing Nodular Goitres: a Prospective Cohort Study
Histopathology - Incidence of Thyroid Cancer in Long Standing MNG
CompletedUniversity of Khartoum1602017-03-012024-05-09
A Study of a New Leishmania Vaccine Candidate ChAd63-KH
ChAd63-KH - Leishmaniasis, Cutaneous
Phase 2CompletedUniversity of York242016-11-012020-01-28
Gum Arabic as Immunomodulator In Rheumatoid Arthritis Patients
Gum Arabic - Rheumatoid Arthritis
Phase 2UnknownLamis Kaddam452016-06-012016-06-21
A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the Sudan
ASP, SDPQ, 14DPQ - Malaria
Phase 4CompletedMenzies School of Health Research3202015-11-012017-02-01
Intravenous Artesunate and Malaria
artesunate, Quinine - Malaria
Phase 4UnknownUniversity of Khartoum802013-03-012013-03-06
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
rk28 ICT, IT LEISH (rK39), Immunochromatographic HAT test - Visceral Leishmaniasis, Human African Trypanosomiasis
Not applicableCompletedUniversity Hospital, Geneva19272013-01-012016-10-27
Efficacy of Different Drugs to Control Post Root Canal Treatment Pain
Paracetamol, Ibuprofen, Mefenamic Acid - Pain, Postoperative Pain
Phase 2CompletedUniversity of Khartoum1852012-08-012026-08-10
Artemether/Lumefantrine and Vivax Malaria
tablets artemether/lumefantrine - Vivax Malaria
Phase 3CompletedUniversity of Khartoum382011-09-012013-01-17

Showing 20 of 24. Sign in to see all of them.

Conditions studied

Malaria (7)  ·  Kidney Failure, Chronic (2)  ·  Leishmaniasis, Visceral (2)  ·  Abortion, Spontaneous (1)  ·  Anemia, Sickle Cell (1)  ·  Arthritis, Rheumatoid (1)  ·  Brucellosis (1)  ·  COVID-19 (1)  ·  Goiter (1)  ·  Infertility (1)  ·  Insulin Resistance (1)  ·  Leishmaniasis, Cutaneous (1)  ·  Leptospirosis (1)  ·  Liver Abscess, Amebic (1)  ·  Lymphoma, Follicular (1)

Interventions

Gum Arabic (6)  ·  Pectins (2)  ·  Rapid Diagnostic Tests (2)  ·  Acetaminophen (1)  ·  Antilymphocyte Serum (1)  ·  Antimony Sodium Gluconate (1)  ·  Artemether (1)  ·  Artemether, Lumefantrine Drug Combination (1)  ·  Artesunate (1)  ·  Aspirin (1)  ·  Basiliximab (1)  ·  Ceftizoxime (1)  ·  Diclofenac (1)  ·  Enoxaparin (1)  ·  Folic Acid (1)

Countries

Sudan (22)  ·  Indonesia (2)  ·  Cambodia (1)  ·  Democratic Republic of the Congo (1)  ·  Kenya (1)  ·  Libya (1)  ·  Nepal (1)  ·  Peru (1)

Top investigators

Sarra Elamin, MD (2)  ·  Ahmed Musa, MBBS (1)  ·  Alnour Alagib, MBBS,MD,MRCP (1)  ·  Amal M Saeed, MBBS,PhD (1)  ·  Fatima Elhaj, PhD (1)  ·  Imad M Fdl-Elmula, PhD (1)  ·  Moawia M Mukhtar, PhD (1)  ·  Mohamed Elmakki Abdella, MS,FRCSI (1)  ·  Mohamed Osman, PhD (1)  ·  Mohammed Hassan Alnazeer (1)  ·  Mustafa KM Nimeiri, MD (1)  ·  Muzamil Mahdi, PhD (1)  ·  Neamat Abubakr, BDS,MDSc,PhD (1)  ·  Paul Kaye, PhD (1)

Results publications

PMID 10613619, PMID 12148679, PMID 15230906, PMID 17437870, PMID 18498882, PMID 21729382, PMID 23217037, PMID 23383316, PMID 23394621, PMID 24405979, PMID 27080115, PMID 27812090, PMID 28331623, PMID 29548285, PMID 30112005, PMID 32328307, PMID 32891160, PMID 33781913, PMID 35491421, PMID 37870148, PMID 42607090, PMID 9594474

NIH funding

2016 (1)